Clinical Trials Browser

Withdrawn × PT-100 dipeptide × Clear all

NCT00489710 2023-08-22

Talabostat in Treating Patients With Metastatic Kidney Cancer

Phase 2 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04123574 2022-02-24

A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

Phase EARLY_PHASE1 Withdrawn

Gastrointestinal

Neoplasms, Pancreatic Neoplasms